Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.14% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
Ero Copper
ERO
$3.58B
| $36.1M | ﹤0.01% |
1,275,535
+459,971
| +56% | +$10.7M |
|
2402
iShares Investment Grade Systematic Bond ETF
IGEB
$1.51B
| $35.9M | ﹤0.01% |
786,559
+195,893
| +33% | +$8.99M |
|
|
PKST
2403
DELISTED
Peakstone Realty Trust
PKST
| $35.9M | ﹤0.01% |
2,500,507
+676,921
| +37% | +$9.33M |
|
2404
Crinetics Pharmaceuticals
CRNX
$8.96B
| $35.8M | ﹤0.01% |
768,826
+86,692
| +13% | +$3.86M |
|
2405
LeMaitre Vascular
LMAT
$1.87B
| $35.8M | ﹤0.01% |
440,933
+19,327
| +5% | +$1.66M |
|
2406
First Trust Mid Cap Growth AlphaDEX Fund
FNY
$606M
| $35.7M | ﹤0.01% |
391,891
-7,959
| -2% | -$731K |
|
|
HIO
2407
Western Asset High Income Opportunity Fund
HIO
$338M
| $35.7M | ﹤0.01% |
9,632,812
+320,681
| +3% | +$1.21M |
|
2408
Compañía de Minas Buenaventura
BVN
$8.55B
| $35.7M | ﹤0.01% |
1,282,187
+398,861
| +45% | +$9.95M |
|
2409
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.9B
| $35.6M | ﹤0.01% |
389,358
+55,534
| +17% | +$5.06M |
|
2410
ADMA Biologics
ADMA
$2.11B
| $35.5M | ﹤0.01% |
1,948,373
+490,179
| +34% | +$8.26M |
|
|
PPLI
2411
People Inc
PPLI
$3.01B
| $35.5M | ﹤0.01% |
907,984
+44,885
| +5% | +$1.57M |
|
2412
The GEO Group
GEO
$4B
| $35.5M | ﹤0.01% |
2,200,681
-171,485
| -7% | -$2.86M |
|
2413
Payoneer
PAYO
$2.42B
| $35.4M | ﹤0.01% |
6,300,854
+372,227
| +6% | +$2.15M |
|
2414
Aurinia Pharmaceuticals
AUPH
$2.02B
| $35.4M | ﹤0.01% |
2,216,915
+270,130
| +14% | +$3.83M |
|
2415
Dana Inc
DAN
$3.26B
| $35.3M | ﹤0.01% |
1,486,339
+117,763
| +9% | +$2.49M |
|
2416
QuidelOrtho
QDEL
$1.03B
| $35.3M | ﹤0.01% |
1,235,267
+209,317
| +20% | +$5.67M |
|
2417
Home BancShares
HOMB
$6.27B
| $35.3M | ﹤0.01% |
1,269,330
+408,578
| +47% | +$11.3M |
|
2418
Sonoco
SON
$5.77B
| $35.3M | ﹤0.01% |
807,972
+185,351
| +30% | +$7.67M |
|
|
HNGE
2419
Hinge Health
HNGE
$7.05B
| $35.2M | ﹤0.01% |
757,781
+553,412
| +271% | +$26.7M |
|
2420
UFP Technologies
UFPT
$2.48B
| $35.2M | ﹤0.01% |
158,376
-5,462
| -3% | -$1.17M |
|
|
DLY
2421
DoubleLine Yield Opportunities Fund
DLY
$692M
| $35.1M | ﹤0.01% |
2,415,562
-23,851
| -1% | -$350K |
|
|
CNR
2422
Core Natural Resources Inc
CNR
$4.64B
| $35.1M | ﹤0.01% |
396,500
-28,598
| -7% | -$2.44M |
|
|
MZTI
2423
The Marzetti Company
MZTI
$3.22B
| $35M | ﹤0.01% |
213,122
-5,180
| -2% | -$864K |
|
2424
CRISPR Therapeutics
CRSP
$5.22B
| $35M | ﹤0.01% |
667,060
-730,799
| -52% | -$43.8M |
|
2425
Palomar
PLMR
$3.37B
| $35M | ﹤0.01% |
259,484
-24,289
| -9% | -$2.96M |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,946 increased, 2,962 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.